4978 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
ReproCELL, Inc. engages in stem cell research. It operates through the following segments: Research Support and Medical. The Research Support segment includes reagents and drug discovery support in the Induced Pluripotent Stem (iPS) cell business. The Medical segment deals with regenerative medicine in the iPS cell business and clinical testing services. The company was founded by Norio Nakatsuji and Hiromitsu Nakauchi on February 26, 2003 and is headquartered in Yokohama, Japan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
4978 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company